{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T19:26:59Z","timestamp":1740166019904,"version":"3.37.3"},"reference-count":77,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2021,5,5]],"date-time":"2021-05-05T00:00:00Z","timestamp":1620172800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,5,5]],"date-time":"2021-05-05T00:00:00Z","timestamp":1620172800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Nutr Rep"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1007\/s13668-021-00356-2","type":"journal-article","created":{"date-parts":[[2021,5,5]],"date-time":"2021-05-05T03:44:48Z","timestamp":1620186288000},"page":"200-210","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Keeping a Balance During the Pandemic: a Narrative Review on the Important Role of Micronutrients in Preventing Infection and Reducing Complications of COVID-19"],"prefix":"10.1007","volume":"10","author":[{"given":"Nathan Ushmantha","family":"Pinnawala","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tinna Osk","family":"Thrastardottir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6167-4023","authenticated-orcid":false,"given":"Constantina","family":"Constantinou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,5,5]]},"reference":[{"key":"356_CR1","doi-asserted-by":"publisher","first-page":"102433","DOI":"10.1016\/j.jaut.2020.102433","volume":"109","author":"H Rothan","year":"2020","unstructured":"Rothan H, Byrareddy S. The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak. J Autoimmun. 2020;109:102433. https:\/\/doi.org\/10.1016\/j.jaut.2020.102433This review provides a thorough description of the epidemiology and pathogenesis of SARS-CoV-2, accounting for its origin, symptomology, transmission, and therapeutic targets.","journal-title":"J Autoimmun"},{"key":"356_CR2","unstructured":"World Health Organisation Coronavirus Disease (COVID-19) Dashboard. 2021. Available at: https:\/\/covid19.who.int\/. Accessed on January 19, 2021."},{"issue":"20","key":"356_CR3","doi-asserted-by":"publisher","first-page":"1648","DOI":"10.1161\/CIRCULATIONAHA.120.046941","volume":"141","author":"K Clerkin","year":"2020","unstructured":"Clerkin K, Fried J, Raikhelkar J, Sayer G, Griffin J, Masoumi A, et al. COVID-19 and Cardiovascular Disease. Circulation. 2020;141(20):1648\u201355. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.120.046941.","journal-title":"Circulation."},{"issue":"6","key":"356_CR4","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1007\/s10096-020-03874-z","volume":"39","author":"H Ge","year":"2020","unstructured":"Ge H, Wang X, Yuan X, Xiao G, Wang C, Deng T, et al. The epidemiology and clinical information about COVID-19. Eur J Clin Microbiol Infect Dis. 2020;39(6):1011\u20139. https:\/\/doi.org\/10.1007\/s10096-020-03874-zThis review provides a comprehensive understanding of the various features behind COVID-19: underlying genetics, epidemiology, clinical manifestations, treatment, and prognosis.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"356_CR5","doi-asserted-by":"publisher","first-page":"109767","DOI":"10.1016\/j.mehy.2020.109767","volume":"140","author":"M Silberstein","year":"2020","unstructured":"Silberstein M. Vitamin D: a simpler alternative to tocilizumab for trial in COVID-19? Med Hypotheses. 2020;140:109767. https:\/\/doi.org\/10.1016\/j.mehy.2020.109767This article provides an insight into the role of Vitamin D in the modulation of cytokine production and thus control of COVID-19 clinical features.","journal-title":"Med Hypotheses"},{"issue":"10","key":"356_CR6","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1111\/apt.15764","volume":"51","author":"Y Tian","year":"2020","unstructured":"Tian Y, Rong L. Letter: Covid-19, and vitamin D. Authors' reply. Aliment Pharmacol Ther. 2020;51(10):995\u20136. https:\/\/doi.org\/10.1111\/apt.15764.","journal-title":"Aliment Pharmacol Ther"},{"key":"356_CR7","unstructured":"European Medicines Agency. Treatments and vaccines for Covid-19. 2021. Available on https:\/\/www.ema.europa.eu\/en\/human-regulatory\/overview\/public-health-threats\/coronavirus-disease-covid-19\/treatments-vaccines-covid-19?utm_source=phpList&utm_medium=email&utm_campaign=Covi. Accessed on January 22, 2021."},{"issue":"6","key":"356_CR8","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1016\/j.accpm.2020.10.006","volume":"39","author":"C Locht","year":"2020","unstructured":"Locht C. Vaccines against COVID-19. Anaesth Crit Care Pain Med. 2020;39(6):703\u20135. https:\/\/doi.org\/10.1016\/j.accpm.2020.10.006.","journal-title":"Anaesth Crit Care Pain Med"},{"issue":"27","key":"356_CR9","doi-asserted-by":"publisher","first-page":"2603","DOI":"10.1056\/NEJMoa2034577","volume":"383","author":"FP Polack","year":"2020","unstructured":"Polack FP, Thomas SJ, Kitchin N, et al. Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine. N Engl J Med. 2020;383(27):2603\u201315. https:\/\/doi.org\/10.1056\/NEJMoa2034577This article examines the safety and efficacy of the BNT162b2 mRNA Covid-19 Vaccine. The researchers report that a two-dose regimen conferred 95% protection in individuals 16 years or older.","journal-title":"N Engl J Med"},{"issue":"50","key":"356_CR10","doi-asserted-by":"publisher","first-page":"1922","DOI":"10.15585\/mmwr.mm6950e2","volume":"69","author":"S Oliver","year":"2020","unstructured":"Oliver S, Gargano J, Marin M, Wallace M, Curran K, Chamberland M, et al. The Advisory Committee on Immunization Practices\u2019 Interim Recommendation for Use of Pfizer-BioNTech COVID-19 Vaccine \u2014 United States, December 2020. MMWR Morb Mortal Wkly Rep. 2020;69(50):1922\u20134.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"356_CR11","doi-asserted-by":"publisher","unstructured":"Baden LR, El Sahly HM, Essink B, Kotloff K, Frey S, Novak R, et al. N Engl J Med. 2020:NEJMoa2035389. https:\/\/doi.org\/10.1056\/NEJMoa2035389This article examines the safety and efficacy of the mRNA-1273 SARS-CoV-2 vaccine. They found that a two-dose regimen conferred 94.1% protection in persons at high risk for SARS-CoV-2 infection or its complications.","DOI":"10.1056\/NEJMoa2035389"},{"issue":"10269","key":"356_CR12","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/S0140-6736(20)32623-4","volume":"397","author":"M Knoll","year":"2021","unstructured":"Knoll M, Wonodi C. Oxford\u2013AstraZeneca COVID-19 vaccine efficacy. Lancet. 2021;397(10269):72\u20134.","journal-title":"Lancet"},{"issue":"10269","key":"356_CR13","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/S0140-6736(20)32661-1","volume":"397","author":"M Voysey","year":"2021","unstructured":"Voysey M, Clemens S, Madhi S, Weckx L, Folegatti P, Aley P, et al. Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK. Lancet. 2021;397(10269):99\u2013111.4.","journal-title":"Lancet"},{"key":"356_CR14","doi-asserted-by":"publisher","unstructured":"Rochwerg B, Siemieniuk RA, Agoritsas T, Lamontagne F, Askie L, Lytvyn L, et al. A living WHO guideline on drugs for covid-19. BMJ. 2020;370:m3379. https:\/\/doi.org\/10.1136\/bmj.m3379.","DOI":"10.1136\/bmj.m3379"},{"issue":"4","key":"356_CR15","doi-asserted-by":"publisher","first-page":"287","DOI":"10.7326\/M20-2496","volume":"173","author":"A Hernandez","year":"2020","unstructured":"Hernandez A, Roman Y, Pasupuleti V, Barboza J, White C. Hydroxychloroquine or chloroquine for treatment or prophylaxis of COVID-19. Ann Intern Med. 2020;173(4):287\u201396.","journal-title":"Ann Intern Med"},{"key":"356_CR16","doi-asserted-by":"crossref","unstructured":"Alhumaid S, Al Mutair A, Al Alawi Z, Alhmeed N, Zaidi ARZ, Tobaiqy M. Efficacy and safety of lopinavir\/ritonavir for treatment of COVID-19: a systematic review and meta-analysis. Trop Med Infect Dis. 2020;5(4):\u2013180.","DOI":"10.3390\/tropicalmed5040180"},{"key":"356_CR17","doi-asserted-by":"publisher","unstructured":"Bhimraj A, Morgan RL, Shumaker AH, Lavergne V, Baden L, Cheng VC, et al. Infectious Diseases Society of America Guidelines on the Treatment and Management of Patients with COVID-19. Clin Infect Dis. 2020 Apr 27:ciaa478. https:\/\/doi.org\/10.1093\/cid\/ciaa478.","DOI":"10.1093\/cid\/ciaa478"},{"issue":"20","key":"356_CR18","first-page":"30690-X","volume":"S1198-743X","author":"IM Tleyjeh","year":"2020","unstructured":"Tleyjeh IM, Kashour Z, Damlaj M, Riaz M, Tlayjeh H, Altannir M, et al. Efficacy and safety of tocilizumab in COVID-19 patients: a living systematic review and meta-analysis. Clin Microbiol Infect. 2020;S1198-743X(20):30690-X.","journal-title":"Clin Microbiol Infect"},{"issue":"3","key":"356_CR19","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1056\/NEJMoa2035002","volume":"384","author":"DM Weinreich","year":"2020","unstructured":"Weinreich DM, Sivapalasingam S, Norton T, Ali S, Gao H, Bhore R, et al. REGN-COV2, a neutralizing antibody cocktail, in outpatients with Covid-19. N Engl J Med. 2020;384(3):238\u201351. https:\/\/doi.org\/10.1056\/NEJMoa2035002.","journal-title":"N Engl J Med"},{"key":"356_CR20","doi-asserted-by":"publisher","first-page":"A5","DOI":"10.1016\/j.ajo.2020.04.028","volume":"216","author":"S McPherson","year":"2020","unstructured":"McPherson S, Keunen J, Bird A, Chew E, van Kuijk F. Investigate oral zinc as a prophylactic treatment for those at risk for COVID-19. Am J Ophthalmol. 2020;216:A5\u20136. https:\/\/doi.org\/10.1016\/j.ajo.2020.04.028This review looks into the potential use of zinc as a safe and widely used prophylactic treatment option against COVID-19. Zinc has been suggested to have anti-viral properties inhibiting the vital interaction between SARS-CoV-2 S glycoprotein and the ACE2 enzyme essential for the replication of SARS-CoV-2.","journal-title":"Am J Ophthalmol"},{"issue":"2","key":"356_CR21","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1002\/jmv.26408","volume":"93","author":"S Sarkar","year":"2020","unstructured":"Sarkar S, Soni KD, Khanna P. Convalescent plasma is a clutch at straws in COVID-19 management! A systematic review and meta-analysis. J Med Virol. 2020;93(2):1111\u20138. https:\/\/doi.org\/10.1002\/jmv.26408.","journal-title":"J Med Virol"},{"issue":"2","key":"356_CR22","first-page":"198","volume":"28","author":"S Esposito","year":"2020","unstructured":"Esposito S, Noviello S, Pagliano P. Update on treatment of COVID-19: ongoing studies between promising and disappointing results. Infez Med. 2020;28(2):198\u2013211.","journal-title":"Infez Med"},{"issue":"3","key":"356_CR23","doi-asserted-by":"publisher","first-page":"175","DOI":"10.20944\/preprints202004.0006.v1","volume":"251","author":"M Razzaque","year":"2020","unstructured":"Razzaque M. COVID-19 Pandemic: can maintaining optimal zinc balance enhance host resistance? Tohoku J Exp Med. 2020;251(3):175\u201381. https:\/\/doi.org\/10.20944\/preprints202004.0006.v1.","journal-title":"Tohoku J Exp Med"},{"issue":"4","key":"356_CR24","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1016\/j.cell.2018.01.029","volume":"172","author":"S Lambert","year":"2018","unstructured":"Lambert S, Jolma A, Campitelli L, Das P, Yin Y, Albu M, et al. The human transcription factors. Cell. 2018;172(4):650\u201365. https:\/\/doi.org\/10.1016\/j.cell.2018.01.029.","journal-title":"Cell."},{"issue":"11","key":"356_CR25","doi-asserted-by":"publisher","first-page":"e1001176","DOI":"10.1371\/journal.ppat.1001176","volume":"6","author":"A te Velthuis","year":"2010","unstructured":"te Velthuis A, van den Worm S, Sims A, Baric R, Snijder E, van Hemert M. Zn2+ inhibits coronavirus and arterivirus RNA polymerase activity in vitro and zinc ionophores block the replication of these viruses in cell culture. PLoS Pathog. 2010;6(11):e1001176. https:\/\/doi.org\/10.1371\/journal.ppat.1001176.","journal-title":"PLoS Pathog"},{"issue":"4","key":"356_CR26","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.1099\/vir.0.82634-0","volume":"88","author":"K Lanke","year":"2007","unstructured":"Lanke K, Krenn B, Melchers W, Seipelt J, van Kuppeveld F. PDTC inhibits picornavirus polyprotein processing and RNA replication by transporting zinc ions into cells. J Gen Virol. 2007;88(4):1206\u201317. https:\/\/doi.org\/10.1099\/vir.0.82634-0.","journal-title":"J Gen Virol"},{"issue":"1","key":"356_CR27","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3892\/ijmm.2020.4575","volume":"46","author":"A Skalny","year":"2020","unstructured":"Skalny A, Rink L, Ajsuvakova O, Aschner M, Gritsenko V, Alekseenko S, et al. Zinc and respiratory tract infections: perspectives for COVID-19 (Review). Int J Mol Med. 2020;46(1):17\u201326. https:\/\/doi.org\/10.3892\/ijmm.2020.4575This review looks into zinc\u2019s possible role as an adjuvant therapy against COVID-19 through its protective role in reducing inflammation, lessening the cytochrome storm, improving the membrane barrier function and mucociliary clearance of the epithelial cells in the respiratory tract.","journal-title":"Int J Mol Med"},{"key":"356_CR28","doi-asserted-by":"publisher","unstructured":"Sheybani Z, Dokoohaki MH, Negahdaripour M, Dehdashti M, Zolghadr H, Moghadami M, et al. The role of folic acid in the management of respiratory disease caused by COVID-19. 2020. https:\/\/doi.org\/10.26434\/chemrxiv.12034980.v1This review discusses the structure of the viral surface spike proteins which SARS-CoV-2 utilises to gain entry into the target respiratory cells. Highlighting the potential of folic acid to be a novel inhibitor of the surface enzyme Furin, a required enzyme for proteolytic activation of surface proteins facilitating viral entry.","DOI":"10.26434\/chemrxiv.12034980.v1"},{"issue":"1","key":"356_CR29","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1136\/bmjnph-2020-000085","volume":"3","author":"P Calder","year":"2020","unstructured":"Calder P. Nutrition, immunity and COVID-19. BMJ Nutr Prev Health. 2020;3(1):74\u201392. https:\/\/doi.org\/10.1136\/bmjnph-2020-000085This review discusses the importance of several vitamins and minerals in supporting the immune system and fight against infections and more specifically in reducing the cytokine storm characteristic of COVID-19 pathogenesis.","journal-title":"BMJ Nutr Prev Health"},{"key":"356_CR30","doi-asserted-by":"publisher","unstructured":"Ghaffari H, Tavakoli A, Moradi A, Tabarraei A, Bokharaei-Salim F, Zahmatkeshan M, et al. Inhibition of H1N1 influenza virus infection by zinc oxide nanoparticles: another emerging application of nanomedicine. J Biomed Sci. 2019;26(1). https:\/\/doi.org\/10.1186\/s12929-019-0563-4.","DOI":"10.1186\/s12929-019-0563-4"},{"issue":"3","key":"356_CR31","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1128\/aac.48.3.783-790.2004","volume":"48","author":"R Suara","year":"2004","unstructured":"Suara R, Crowe J. Effect of zinc salts on respiratory syncytial virus replication. Antimicrob Agents Chemother. 2004;48(3):783\u201390. https:\/\/doi.org\/10.1128\/aac.48.3.783-790.2004.","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"356_CR32","doi-asserted-by":"publisher","first-page":"1649","DOI":"10.1128\/jvi.73.2.1649-1654.1999","volume":"73","author":"E Ferrari","year":"1999","unstructured":"Ferrari E, Wright-Minogue J, Fang J, Baroudy B, Lau J, Hong Z. Characterization of soluble hepatitis C virus RNA-dependent RNA polymerase expressed in Escherichia coli. J Virol. 1999;73(2):1649\u201354. https:\/\/doi.org\/10.1128\/jvi.73.2.1649-1654.1999.","journal-title":"J Virol"},{"issue":"6","key":"356_CR33","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1016\/s0022-3476(99)70086-7","volume":"135","author":"Z Bhutta","year":"1999","unstructured":"Bhutta Z, Black R, Brown K, Gardner J, Gore S, Hidayat A, et al. Prevention of diarrhea and pneumonia by zinc supplementation in children in developing countries: pooled analysis of randomized controlled trials. J Pediatr. 1999;135(6):689\u201397. https:\/\/doi.org\/10.1016\/s0022-3476(99)70086-7.","journal-title":"J Pediatr"},{"issue":"10229","key":"356_CR34","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1016\/S0140-6736(20)30628-0","volume":"395","author":"P Mehta","year":"2020","unstructured":"Mehta P, McAuley D, Brown M, Sanchez E, Tattersall R, Manson J. COVID-19: consider cytokine storm syndromes and immunosuppression. Lancet. 2020;395(10229):1033\u20134. https:\/\/doi.org\/10.1016\/S0140-6736(20)30628-0.","journal-title":"Lancet."},{"issue":"8","key":"356_CR35","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1089\/jir.1997.17.469","volume":"17","author":"I Cackman","year":"1997","unstructured":"Cackman I, Kirchner H, Rink L. Zinc supplementation reconstitutes the production of interferon-\u03b1 by leukocytes from elderly persons. J Interf Cytokine Res. 1997;17(8):469\u201372. https:\/\/doi.org\/10.1089\/jir.1997.17.469.","journal-title":"J Interf Cytokine Res"},{"key":"356_CR36","doi-asserted-by":"publisher","unstructured":"Bauer S, Kapoor A, Rath M, Thomas S. What is the role of supplementation with ascorbic acid, zinc, vitamin D, or N-acetylcysteine for prevention or treatment of COVID-19? Cleve Clin J Med. 2020. https:\/\/doi.org\/10.3949\/ccjm.87a.ccc046This article discusses the potential role of supplementation of vitamin C, zinc, and vitamin D for the prevention and treatment of COVID-19. These vitamins and minerals have a role in reducing inflammation and promoting the immune response in the host.","DOI":"10.3949\/ccjm.87a.ccc046"},{"issue":"1","key":"356_CR37","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1136\/bmjnph-2020-000071","volume":"3","author":"E Derbyshire","year":"2020","unstructured":"Derbyshire E, Delange J. COVID-19: is there a role for immunonutrition, particularly in the over 65s? BMJ Nutr Prev Health. 2020;3(1):100\u20135. https:\/\/doi.org\/10.1136\/bmjnph-2020-000071.","journal-title":"BMJ Nutr Prev Health"},{"key":"356_CR38","doi-asserted-by":"publisher","first-page":"100193","DOI":"10.1016\/j.phanu.2020.100193","volume":"12","author":"F Galli","year":"2020","unstructured":"Galli F, Reglero G, Bartolini D, Visioli F. Better prepare for the next one. Lifestyle lessons from the COVID-19 pandemic. PharmaNutrition. 2020;12:100193. https:\/\/doi.org\/10.1016\/j.phanu.2020.100193This review identifies factors shown to reduce the burden of disease following the COVID-19 pandemic. The highlighted features include the essential role of confinement and healthy lifestyles and nutrition emphasizing the importance of micronutrients and vitamins as immunoprotective agents.","journal-title":"PharmaNutrition"},{"key":"356_CR39","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s12011-020-02194-9","volume":"199","author":"M Rahman","year":"2020","unstructured":"Rahman M, Idid S. Can Zn be a critical element in COVID-19 treatment? Biol Trace Elem Res. 2020;199:1\u20139. https:\/\/doi.org\/10.1007\/s12011-020-02194-9.","journal-title":"Biol Trace Elem Res"},{"issue":"3","key":"356_CR40","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1093\/ajcn\/85.3.837","volume":"85","author":"A Prasad","year":"2007","unstructured":"Prasad A, Beck F, Bao B, Fitzgerald J, Snell D, Steinberg J, et al. Zinc supplementation decreases incidence of infections in the elderly: effect of zinc on generation of cytokines and oxidative stress. Am J Clin Nutr. 2007;85(3):837\u201344. https:\/\/doi.org\/10.1093\/ajcn\/85.3.837.","journal-title":"Am J Clin Nutr"},{"issue":"5","key":"356_CR41","doi-asserted-by":"publisher","first-page":"1399S","DOI":"10.1093\/jn\/130.5.1399S","volume":"130","author":"P Fraker","year":"2000","unstructured":"Fraker P, King L, Laakko T, Vollmer T. The dynamic link between the integrity of the immune system and zinc status. J Nutr. 2000;130(5):1399S\u2013406S. https:\/\/doi.org\/10.1093\/jn\/130.5.1399S.","journal-title":"J Nutr"},{"key":"356_CR42","first-page":"589","volume":"34","author":"S Sazawal","year":"1997","unstructured":"Sazawal S, Black RE, Jalla S, Mazumdar S, Sinha A, Bhan MK. Effect of zinc supplementation on cell-mediated immunity and lymphocyte subsets in preschool children. Indian Pediatr. 1997;34:589\u201397.","journal-title":"Indian Pediatr"},{"issue":"11","key":"356_CR43","doi-asserted-by":"publisher","first-page":"e50568","DOI":"10.1371\/journal.pone.0050568","volume":"7","author":"K Wessells","year":"2012","unstructured":"Wessells K, Brown K. Estimating the global prevalence of zinc deficiency: results based on zinc availability in national food supplies and the prevalence of stunting. PLoS One. 2012;7(11):e50568. https:\/\/doi.org\/10.1371\/journal.pone.0050568.","journal-title":"PLoS One"},{"issue":"2","key":"356_CR44","first-page":"192","volume":"28","author":"MO Shittu","year":"2018","unstructured":"Shittu MO, Afolami OI. Improving the efficacy of chloroquine and hydroxychloroquine against SARS-CoV-2 may require zinc additives\u2014a better synergy for future COVID-19 clinical trials. Infez Med. 2018;28(2):192\u20137 This review highlights the potential benefit of using zinc and chloroquine in the fight against COVID-19. Chloroquine is able to induce the uptake of zinc into cells ultimately inhibiting its replication through the inhibition of RNA-dependent RNA polymerase.","journal-title":"Infez Med"},{"key":"356_CR45","doi-asserted-by":"publisher","first-page":"109815","DOI":"10.1016\/j.mehy.2020.109815","volume":"142","author":"R Derwand","year":"2020","unstructured":"Derwand R, Scholz M. Does zinc supplementation enhance the clinical efficacy of chloroquine\/hydroxychloroquine to win today's battle against COVID-19? Med Hypotheses. 2020;142:109815. https:\/\/doi.org\/10.1016\/j.mehy.2020.109815.","journal-title":"Med Hypotheses"},{"issue":"4","key":"356_CR46","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.mpmed.2017.01.007","volume":"45","author":"R Moll","year":"2017","unstructured":"Moll R, Davis B. Iron, vitamin B 12 and folate. Medicine. 2017;45(4):198\u2013203. https:\/\/doi.org\/10.1016\/j.mpmed.2017.01.007.","journal-title":"Medicine."},{"issue":"1","key":"356_CR47","doi-asserted-by":"publisher","first-page":"21","DOI":"10.3945\/an.111.000992","volume":"3","author":"K Crider","year":"2012","unstructured":"Crider K, Yang T, Berry R, Bailey L. Folate and DNA methylation: a review of molecular mechanisms and the evidence for folate's role. Adv Nutr. 2012;3(1):21\u201338. https:\/\/doi.org\/10.3945\/an.111.000992.","journal-title":"Adv Nutr"},{"key":"356_CR48","doi-asserted-by":"publisher","unstructured":"Heiser K, McLean P, Davis C, Fogelson B, Gordon H, Jacobson P, et al. Identification of potential treatments for COVID-19 through artificial intelligence-enabled phenomic analysis of human cells infected with SARS-CoV-2 (Preprint). 2020. https:\/\/doi.org\/10.1101\/2020.04.21.054387.","DOI":"10.1101\/2020.04.21.054387"},{"key":"356_CR49","doi-asserted-by":"publisher","unstructured":"Maggini S, Wintergerst E, Beveridge S, Hornig D. Contribution of selected vitamins and trace elements to immune function. Proc Nutr Soc. 2008;67(OCE1). https:\/\/doi.org\/10.1017\/s0029665108006939.","DOI":"10.1017\/s0029665108006939"},{"issue":"11","key":"356_CR50","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.3390\/nu9111211","volume":"9","author":"A Carr","year":"2017","unstructured":"Carr A, Maggini S. Vitamin C and immune function. Nutrients. 2017;9(11):1211. https:\/\/doi.org\/10.3390\/nu9111211.","journal-title":"Nutrients."},{"issue":"3","key":"356_CR51","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1556\/1886.2019.00016","volume":"9","author":"S Mousavi","year":"2019","unstructured":"Mousavi S, Bereswill S, Heimesaat M. Immunomodulatory and antimicrobial effects of vitamin C. Eur J Microbiol Immunol. 2019;9(3):73\u20139. https:\/\/doi.org\/10.1556\/1886.2019.00016.","journal-title":"Eur J Microbiol Immunol"},{"key":"356_CR52","doi-asserted-by":"publisher","unstructured":"Erol A. High-dose intravenous vitamin C treatment for COVID-19. 2020. Available on: https:\/\/osf.io\/p7ex8\/?fbclid=IwAR2b67345SBs9r2QfJ23xH_0GEM771Qwww6EPpOSTSpQ7_x2BUu7-5CZEHo. https:\/\/doi.org\/10.31219\/osf.io\/p7ex8. Accessed August 18 2020. This review suggests the possible role of high-dose intravenous vitamin C as a treatment option for the early stages of COVID-19 as this has been shown to be effective against sepsis and septic shock.","DOI":"10.31219\/osf.io\/p7ex8"},{"issue":"4","key":"356_CR53","doi-asserted-by":"publisher","first-page":"2574","DOI":"10.3390\/nu7042574","volume":"7","author":"S Bozonet","year":"2015","unstructured":"Bozonet S, Carr A, Pullar J, Vissers M. Enhanced human neutrophil vitamin C status, chemotaxis and oxidant generation following dietary supplementation with vitamin C-rich SunGold Kiwifruit. Nutrients. 2015;7(4):2574\u201388. https:\/\/doi.org\/10.3390\/nu7042574.","journal-title":"Nutrients."},{"issue":"4","key":"356_CR54","doi-asserted-by":"publisher","first-page":"C652","DOI":"10.1152\/ajpcell.00076.2016","volume":"311","author":"W Parker","year":"2016","unstructured":"Parker W, Rhea E, Qu Z, Hecker M, May J. Intracellular ascorbate tightens the endothelial permeability barrier through Epac1 and the tubulin cytoskeleton. Am J Phys Cell Phys. 2016;311(4):C652\u201362. https:\/\/doi.org\/10.1152\/ajpcell.00076.2016.","journal-title":"Am J Phys Cell Phys"},{"key":"356_CR55","doi-asserted-by":"publisher","first-page":"100028","DOI":"10.1016\/j.medidd.2020.100028","volume":"5","author":"R Cheng","year":"2020","unstructured":"Cheng R. Can early and high intravenous dose of vitamin C prevent and treat coronavirus disease 2019 (COVID-19)? Med Drug Discov. 2020;5:100028. https:\/\/doi.org\/10.1016\/j.medidd.2020.100028This review suggests the use of high dose oral vitamin C for the treatment against COVID-19. Vitamin C\u2019s antioxidant role has been shown to reduce the effect of the cytokine storm observed in patients with SARS-CoV-2 infection.","journal-title":"Med Drug Discov"},{"issue":"4","key":"356_CR56","doi-asserted-by":"publisher","first-page":"708","DOI":"10.3390\/nu11040708","volume":"11","author":"H Hemil\u00e4","year":"2019","unstructured":"Hemil\u00e4 H, Chalker E. Vitamin C can shorten the length of stay in the ICU: a meta-analysis. Nutrients. 2019;11(4):708. https:\/\/doi.org\/10.3390\/nu11040708.","journal-title":"Nutrients."},{"issue":"13","key":"356_CR57","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1001\/jama.2019.11825","volume":"322","author":"A Fowler","year":"2019","unstructured":"Fowler A, Truwit J, Hite R, Morris P, DeWilde C, Priday A, et al. Effect of vitamin C infusion on organ failure and biomarkers of inflammation and vascular injury in patients with sepsis and severe acute respiratory failure. JAMA. 2019;322(13):1261\u201370. https:\/\/doi.org\/10.1001\/jama.2019.11825.","journal-title":"JAMA."},{"key":"356_CR58","unstructured":"Clinicaltrials.gov. Vitamin C infusion for the treatment of severe 2019-nCoV infected pneumonia' (Identifier: NCT04264533). 2020. Retrieved 18 August 2020, from https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04264533?term=NCT04264533&draw=2&rank=1. Accessed August 18 2020."},{"issue":"1","key":"356_CR59","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s13613-020-00792-3","volume":"11","author":"J Zhang","year":"2021","unstructured":"Zhang J, Rao X, Li Y, Zhu Y, Liu F, Guo G, et al. Pilot trial of high-dose vitamin C in critically ill COVID-19 patients. Ann Intensive Care. 2021;11(1):5. https:\/\/doi.org\/10.1186\/s13613-020-00792-3.","journal-title":"Ann Intensive Care"},{"key":"356_CR60","unstructured":"Clinicaltrials.gov. Early infusion of vitamin C for treatment of novel COVID-19 acute lung injury (EVICT-CORONA-ALI) (Identifier: NCT04344184). 2020. Retrieved 18 August 2020, from https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04344184?term=NCT04344184&draw=2&rank=1. Accessed August 18 2020."},{"issue":"1","key":"356_CR61","doi-asserted-by":"publisher","first-page":"50","DOI":"10.4065\/mcp.2010.0567","volume":"86","author":"T Thacher","year":"2011","unstructured":"Thacher T, Clarke B. Vitamin D insufficiency. Mayo Clin Proc. 2011;86(1):50\u201360. https:\/\/doi.org\/10.4065\/mcp.2010.0567.","journal-title":"Mayo Clin Proc"},{"issue":"6","key":"356_CR62","doi-asserted-by":"publisher","first-page":"4240","DOI":"10.3390\/nu7064240","volume":"7","author":"C Greiller","year":"2015","unstructured":"Greiller C, Martineau A. Modulation of the immune response to respiratory viruses by vitamin D. Nutrients. 2015;7(6):4240\u201370. https:\/\/doi.org\/10.3390\/nu7064240.","journal-title":"Nutrients."},{"issue":"3","key":"356_CR63","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.jcv.2010.12.006","volume":"50","author":"JA Beard","year":"2011","unstructured":"Beard JA, Bearden A, Striker R. Vitamin D and the antiviral state. J Clin Virol. 2011;50(3):194\u2013200. https:\/\/doi.org\/10.1016\/j.jcv.2010.12.006.","journal-title":"J Clin Virol"},{"issue":"4","key":"356_CR64","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1016\/j.coph.2010.04.001","volume":"10","author":"F Baeke","year":"2010","unstructured":"Baeke F, Takiishi T, Korf H, Gysemans C, Mathieu C. Vitamin D: modulator of the immune system. Curr Opin Pharmacol. 2010;10(4):482\u201396. https:\/\/doi.org\/10.1016\/j.coph.2010.04.001.","journal-title":"Curr Opin Pharmacol"},{"issue":"5","key":"356_CR65","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1007\/s00109-010-0590-9","volume":"88","author":"D Kamen","year":"2010","unstructured":"Kamen D, Tangpricha V. Vitamin D and molecular actions on the immune system: modulation of innate and autoimmunity. J Mol Med. 2010;88(5):441\u201350. https:\/\/doi.org\/10.1007\/s00109-010-0590-9.","journal-title":"J Mol Med"},{"key":"356_CR66","doi-asserted-by":"publisher","unstructured":"Arboleda J, Urcuqui-Inchima S. Vitamin D supplementation: a potential approach for coronavirus\/COVID-19 therapeutics? Front Immunol. 2020;11. https:\/\/doi.org\/10.3389\/fimmu.2020.01523.","DOI":"10.3389\/fimmu.2020.01523"},{"issue":"5","key":"356_CR67","doi-asserted-by":"publisher","first-page":"E589","DOI":"10.1152\/ajpendo.00138.2020","volume":"318","author":"H Jakovac","year":"2020","unstructured":"Jakovac H. COVID-19 and vitamin D\u2014Is there a link and an opportunity for intervention? Am J Physiol Endocrinol Metab. 2020;318(5):E589. https:\/\/doi.org\/10.1152\/ajpendo.00138.2020This review highlights the therapeutic benefits of vitamin D in modulating viral replication and subsequent viral mediated respiratory inflammation. The researchers emphasise the importance of investigating Vitamin D as a prophylactic and adjuvant therapy in the context of viral infection.","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"6","key":"356_CR68","doi-asserted-by":"publisher","first-page":"1620","DOI":"10.20944\/preprints202003.0235.v2","volume":"12","author":"W Grant","year":"2020","unstructured":"Grant W, Baggerly C, Lahore H. Reply: \u201cVitamin D supplementation in influenza and COVID-19 infections. Comment on: Evidence that vitamin D supplementation could reduce risk of influenza and COVID-19 infections and deaths nutrients 2020, 12(4), 988\u201d. Nutrients. 2020;12(6):1620. https:\/\/doi.org\/10.20944\/preprints202003.0235.v2.","journal-title":"Nutrients"},{"key":"356_CR69","doi-asserted-by":"publisher","unstructured":"Honardoost M, Ghavideldarestani M, Khamseh ME. Role of vitamin D in pathogenesis and severity of COVID-19 infection. Arch Physiol Biochem. 2020:1\u20137. https:\/\/doi.org\/10.1080\/13813455.2020.1792505This article highlights the role of vitamin D in the pathogenesis and severity of COVID-19 infection by disrupting the interaction between the virus and target cells but also via enhancing the host's immunological potential.","DOI":"10.1080\/13813455.2020.1792505"},{"key":"356_CR70","doi-asserted-by":"publisher","unstructured":"Gowda P, Sen E. Involvement of bradykinin and folate receptor in calming the SARS-COV2 cytokine storm: lessons learnt from lung cancer Research Square (preprint). https:\/\/doi.org\/10.21203\/rs.3.rs-23656\/v.","DOI":"10.21203\/rs.3.rs-23656\/v"},{"key":"356_CR71","doi-asserted-by":"publisher","first-page":"117808","DOI":"10.1016\/j.lfs.2020.117808","volume":"254","author":"V Mart\u00edn Gim\u00e9nez","year":"2020","unstructured":"Mart\u00edn Gim\u00e9nez V, Inserra F, Tajer C, Mariani J, Ferder L, Reiter R, et al. Lungs as target of COVID-19 infection: protective common molecular mechanisms of vitamin D and melatonin as a new potential synergistic treatment. Life Sci. 2020;254:117808. https:\/\/doi.org\/10.1016\/j.lfs.2020.117808.","journal-title":"Life Sci"},{"issue":"7","key":"356_CR72","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.1002\/oby.22838","volume":"28","author":"S Carter","year":"2020","unstructured":"Carter S, Baranauskas M, Fly A. Considerations for obesity, vitamin D, and physical activity amid the COVID-19 pandemic. Obesity. 2020;28(7):1176\u20137. https:\/\/doi.org\/10.1002\/oby.22838.","journal-title":"Obesity"},{"issue":"1","key":"356_CR73","doi-asserted-by":"publisher","first-page":"51","DOI":"10.4161\/derm.24494","volume":"5","author":"M Wacker","year":"2013","unstructured":"Wacker M, Holick MF. Sunlight and vitamin D. Dermato-Endocrinology. 2013;5(1):51\u2013108. https:\/\/doi.org\/10.4161\/derm.24494.","journal-title":"Dermato-Endocrinology."},{"issue":"12","key":"356_CR74","doi-asserted-by":"publisher","first-page":"1434","DOI":"10.1111\/apt.15777","volume":"51","author":"J Rhodes","year":"2020","unstructured":"Rhodes J, Subramanian S, Laird E, Kenny R. Editorial: low population mortality from COVID-19 in countries south of latitude 35 degrees North supports vitamin D as a factor determining severity. Aliment Pharmacol Ther. 2020;51(12):1434\u20137. https:\/\/doi.org\/10.1111\/apt.15777.","journal-title":"Aliment Pharmacol Ther"},{"issue":"5","key":"356_CR75","doi-asserted-by":"publisher","first-page":"284","DOI":"10.3390\/brainsci10050284","volume":"10","author":"C Hribar","year":"2020","unstructured":"Hribar C, Cobbold P, Church F. Potential role of vitamin D in the elderly to resist COVID-19 and to slow progression of Parkinson\u2019s disease. Brain Sci. 2020;10(5):284. https:\/\/doi.org\/10.3390\/brainsci10050284This review highlights the antiviral and immunomodulatory features of vitamin D, which are suggested to play a role in improving Parkinson related pathogenesis. The researchers also discuss how vitamin D may offer antiviral protection from SAR-CoV-2 through immunomodulation.","journal-title":"Brain Sci"},{"issue":"10","key":"356_CR76","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1111\/apt.15752","volume":"51","author":"A Panarese","year":"2020","unstructured":"Panarese A, Shahini E. Letter: Covid-19, and vitamin D. Aliment Pharmacol Ther. 2020;51(10):993\u20135. https:\/\/doi.org\/10.1111\/apt.15752This article examines the function of ACE2 as the docking host receptor for SARS-CoV-2 and its subsequent expression modulated by vitamin D. This review concludes the potential use of vitamin D as prophylaxis in reducing symptom severity of patients who are experiencing hypovitaminosis D.","journal-title":"Aliment Pharmacol Ther"},{"issue":"5","key":"356_CR77","doi-asserted-by":"publisher","first-page":"1466","DOI":"10.3390\/nu12051466","volume":"12","author":"I Zabetakis","year":"2020","unstructured":"Zabetakis I, Lordan R, Norton C, Tsoupras A. COVID-19: the inflammation link and the role of nutrition in potential mitigation. Nutrients. 2020;12(5):1466. https:\/\/doi.org\/10.3390\/nu12051466.","journal-title":"Nutrients."}],"container-title":["Current Nutrition Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13668-021-00356-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13668-021-00356-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13668-021-00356-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,19]],"date-time":"2021-08-19T16:48:58Z","timestamp":1629391738000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13668-021-00356-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,5]]},"references-count":77,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,9]]}},"alternative-id":["356"],"URL":"https:\/\/doi.org\/10.1007\/s13668-021-00356-2","relation":{},"ISSN":["2161-3311"],"issn-type":[{"type":"electronic","value":"2161-3311"}],"subject":[],"published":{"date-parts":[[2021,5,5]]},"assertion":[{"value":"19 April 2021","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 May 2021","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declerations"}},{"value":"The authors declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}